Cyclin E is one of the G1
cyclins that play an important role in cell proliferation. Overexpression of
cyclin E protein has been reported in several solid
tumors, but little is known about the involvement of
cyclin E in
leukemia. In this study, we analyzed the expression of
cyclin E gene product in 85 patients with
acute myelogenous leukemia (AML) by Western blot analysis. In 23 of 85 AML samples (27%),
cyclin E expression was enhanced in blasts. Among the French-American-British classification of AML, the ratio of the samples with enhanced
cyclin E expression was high in M5 and low in M2 and M3. No rearrangements were observed by Southern blot analysis in these AML blasts with enhanced
cyclin E expression. Flow cytometric analysis showed no correlation between overexpression of
cyclin E and cell cycle distribution. Immunoblot analysis of
cyclin D1 showed no correlation between overexpression of
cyclin E and that of
cyclin D1. Interestingly, p27 expression detected by Western blotting was apparently enhanced in 18 of 23 AML cells with enhanced
cyclin E expression but none of 14 AML cells without enhanced
cyclin E exhibited enhanced p27 expression. The rates of complete remission and of disease-free survival of the patients with M4 or M5
leukemia blasts with overexpressed
cyclin E seemed to be low. Therefore, we suggest the necessity of a larger-scale study to elucidate the contribution of
cyclin E overexpression to the phenotype and the prognosis of certain AML.